Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: A systematic review

Resuscitation

Volumn 83, Issue 6, 2012, Pages 674-683

  de Oliveira, Felipe Carvalho ^a,b   Feitosa Filho, Gilson Soares ^a,b   Ritt, Luiz Eduardo Fonteles ^b,c  

^a ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^b HOSPITAL SANTA IZABEL   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Advanced Life Support; Beta blockade; Beta blockers; Cardiopulmonary Resuscitation; Ventricular fibrillation

Indexed keywords

ADRENALIN; ATENOLOL; CARVEDILOL; CATECHOLAMINE; ESMOLOL; PHENYLEPHRINE; PLACEBO; PRAZOSIN; PROPRANOLOL; TROPONIN; VASOPRESSIN; ZATEBRADINE;

CARDIOGENIC SHOCK; CATECHOLAMINE BLOOD LEVEL; DEFIBRILLATION; DRUG MEGADOSE; ELECTRONIC MEDICAL RECORD; HEART ARREST; HEART ARRHYTHMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART PERFUSION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MEDLINE; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SHORT SURVEY; SYSTEMATIC REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARDIOPULMONARY RESUSCITATION; CORONARY CIRCULATION; EPINEPHRINE; HEART ARREST; HUMANS; MYOCARDIUM; OXYGEN CONSUMPTION; PROPANOLAMINES; PROPRANOLOL; TACHYCARDIA, VENTRICULAR; VASOCONSTRICTOR AGENTS; VASOPRESSINS; VENTRICULAR FIBRILLATION;

EID: 84860487124     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2012.01.025     Document Type: Short Survey

References (54)

1. ILCOR Writing Group International Consensus on Cardiopulmonary Resuscitation and Emergency Care Science with Treatment Recommendations. Resuscitation 2010, 81:e1-e332.
2. Cobb L.A., Fahrenbruch C.E., Olsufka M., Copass M.K. Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA 2002, 288:3008-3013.
3. Chugh S.S., Jui J., Gunson K., et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 2004, 44:1268-1275.
4. Estner H.L., Gunzel C., Ndrepepa G., et al. Outcome after out-of-hospital cardiac arrest in a physician staffed emergency medical system according to the Utstein style. Am Heart J 2007, 153:792-799.
5. Dunne R.B., Compton S., Zalenski R.J., Swor R., Welch R., Bock B.F. Outcomes from out-of-hospital cardiac arrest in Detroit. Resuscitation 2007, 72:59-65.
6. Garza A.G., Gratton M.C., Salomone J.A., Lindholm D., McElroy J., Archer R. Improved patient survival using a modified resuscitation protocol for out-of-hospital cardiac arrest. Circulation 2009, 119:2597-2605.
7. Otto C.W., Yakaitis R.W., Blitt C.D. Mechanism of action of epinephrine in resuscitation from asphyxial arrest. Crit Care Med 1981, 9:321-324.
8. Pellis T., Weil M.H., Tang W., et al. Evidence favoring the use of an alpha2-selective vasopressor agent for cardiopulmonary resuscitation. Circulation 2003, 108:2716-2721.
9. Michael J.R., Guerci A.D., Koehler R.C., et al. Mechanisms by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs. Circulation 1984, 69:822-835.
10. Tang W., Weil M.H., Gazmuri R.J., Sun S., Duggal C., Bisera J. Pulmonary ventilation/perfusion defects induced by epinephrine during CPR. Circulation 1991, 84:2101-2107.
11. Hilwig R.W., Kern K.B., Berg R.A., Sanders A.B., Otto C.W., Ewy G.A. Catecholamines in cardiac arrest: role of alpha agonists, beta-adrenergic blockers and high-dose epinephrine. Resuscitation 2000, 47:203-208.
12. Gazmuri R.J., Becker J. Cardiac resuscitation. The search for hemodynamically more effective methods. Chest 1997, 111:712-723.
13. Mckeever W.P., Gregg D.E., Canney P.C. Oxygen uptake of the nonworking left ventricle. Circ Res 1958, 6:612-623.
14. Berglund E., Monroe R.G., Schreiner G.I. Myocardial oxygen consumption and coronary blood flow during potassium-induced cardiac arrest and during ventricular fibrillation. Acta Physiol Scand 1957, 41:261-268.
15. Tang W., Weil M.H., Sun S., Noc M., Yang L., Gazmuri R.J. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995, 92:3089-3093.
16. Tisdale J.E., Patel R.V., Webb C.R., Borzak S., Zarowitz B.J. Proarrhythmic effects of intravenous vasopressors. Ann Pharmacother 1995, 29:269-281.
17. Lehnart S.E., Wehrens X.H., Marks A.R. Calstabin deficiency, ryanodine receptors, and sudden cardiac death. Biochem Biophys Res Commun 2004, 322:1267-1279.
18. Curran J., Hinton M.J., Ríos E., Bers D.M., Shannon T.R. Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiacmyocytes is mediated by calcium/calmodulindependent protein kinase. Circ Res 2007, 100:391-398.
19. Baker J.G. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol 2005, 144:317-322.
20. Badgett R.G., Lawrence V.A., Cohn S.L. Variations in pharmacology of beta-blockers may contribute to heterogeneous results in trials of perioperative beta-blockade. Anesthesiology 2010, 113:585-592.
21. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Ann Intern Med 2009, 151. The PRISMA Group.
22. Ditchey R.V., Rubio-Perez A., Slinker B.K. Beta-adrenergic blockade reduces myocardial injury during experimental cardiopulmonary resuscitation. J Am Coll Cardiol 1994, 24:804-812.
23. Ditchey R.V., Slinker B.K. Phenylephrine plus propranolol improves the balance between myocardial oxygen supply and demand during experimental cardiopulmonary resuscitation. Am Heart J 1994, 127:324-330.
24. Lindner K.H., Brinkmann A., Pfenninger E.G., Lurie K.G., Goertz A., Lindner I.M. Effect of vasopressin on hemodynamic variables, organ blood flow and acid base status in a pig model of cardiopulmonary resuscitation. Anesth Analg 1993, 77:427-435.
25. Lindner K.H., Dirks B., Strohmenger H.U., Prengel A.W., Lindner I.M., Lurie K.G. Randomized comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 1997, 349:535-537.
26. Theochari E., Xanthos T., Papadimitriou D., et al. Selective beta blockade improves the outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest. Ann Ital Chir 2008, 79:409-414.
27. Killingsworth C.R., Wei C.C., Dell'Italia L.J., et al. Short-acting beta-adrenergic antagonist esmolol given at reperfusion improves survival after prolonged ventricular fibrillation. Circulation 2004, 109:2469-2474.
28. Jingjun L., Yan Z., Weijie, Dongdong Z., Guosheng L., Mingwei B. Effect and mechanism of esmolol given during cardiopulmonary resuscitation in a porcine ventricular fibrillation model. Resuscitation 2009, 80:1052-1059.
29. Cammarata G., Weil M.H., Sun S., Tang W., Wang J., Huang L. Beta1-adrenergic blockade during cardiopulmonary resuscitation improves survival. Crit Care Med 2004, 32:S440-S443.
30. Strohmenger H.U., Wenzel V., Eberhard R., Guth B.D., Lurie K.G., Lindner K.H. Effects of the specific bradycardic agent zatebradine on hemodynamic variables and myocardial blood flow during the early postresuscitation phase in pigs. Resuscitation 1999, 42:211-220.
31. Bassiakou E., Xanthos T., Koudouna E., et al. Atenolol in combination with epinephrine improves the initial outcome of cardiopulmonary resuscitation in a swine model of ventricular fibrillation. Am J Emerg Med 2008, 26:578-584.
32. Huang L., Weil M.H., Sun S., Tang W., Fang X. Carvedilol mitigates adverse effects of epinephrine during cardiopulmonary resuscitation. J Cardiovasc Pharmacol Ther 2005, 10:113-120.
33. Bourque D., Daoust R., Huard V., Charneux M. Beta-blockers for the treatment of cardiac arrest from ventricular fibrillation?. Resuscitation 2007, 75:434-444.
34. Nademanee K., Taylor R., Bailey W.E., Rieders D.E., Kosar E.M. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 2000, 102:742-747.
35. Miwa Y., Ikeda T., Mera H., et al. Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. Circ J 2010, 74:856-863.
36. Besterman E.M., Friedlander D.H. Clinical experiences with propranolol. Postgrad Med J 1965, 41:526-535.
37. Sloman G., Robinson J.S., Mclean K. Propranolol (inderal) in persistent ventricular fibrillation. Br Med J 1965, 1:895-896.
38. Iwatsuki K., Yusa T., Hashimoto Y., Watabe Y. Effect of propranolol on paroxysmal ventricular fibrillation. Tohoku J Exp Med 1966, 88:257-262.
39. Ikram H. Propranolol in persistent ventricular fibrillation complicating acute myocardial infarction. Am Heart J 1968, 75:795-798.
40. Rothfeld E.L., Lipowitz M., Zucker I.R., Parsonnet V., Bernstein A. Management of persistently recurring ventricular fibrillation with propranolol hydrochloride. JAMA 1968, 204:546-548.
41. Mason J.R., Marek J.C., Loeb H.S., Scanlon P.J. Intravenous propranolol in the treatment of repetitive ventricular tachyarrhythmias during resuscitation from sudden death. Am Heart J 1985, 110:161-165.
42. van Dantzig J.M., Koster R.W., Biervliet J.D. Treatment with esmolol of ventricular fibrillation unresponsive to lidocaine and procainamide. J Cardiothorac Vasc Anesth 1991, 5:600-603.
43. Schmidt T.D., Muir A.J. A case of electrical storm in a liver transplant patient. Transplant Proc 2003, 35:1437-1438.
44. Srivatsa U.N., Ebrahimi R., El-Bialy A., Wachsner R.Y. Electrical storm: case series and review of management. J Cardiovasc Pharmacol Ther 2003, 8:237-246.
45. Tsagalou E.P., Kanakakis J., Rokas S., Anastasiou-Nana M.I. Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone. Int J Cardiol 2005, 99:341-342.
46. Paradis N.A., Martin G.B., Rivers E.P., et al. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA 1990, 263:1106-1113.
47. Kern K.B., Ewy G.A., Voorhees W.D., Babbs C.F., Tacker W.A. Myocardial perfusion pressure: a predictor of 24-hour survival during prolonged cardiac arrest in dogs. Resuscitation 1988, 16:241-250.
48. Lindner K.H., Haak T., Keller A., Bothner U., Lurie K.G. Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart 1996, 75:145-150.
49. Kern K.B., Elchisak M.A., Sanders A.B., Badylak S.F., Tacker W.A., Ewy G.A. Plasma catecholamines and resuscitation from prolonged cardiac arrest. Crit Care Med 1989, 17:768-791.
50. Bassiakou E., Xanthos T., Papadimitriou L. The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation. Eur J Pharmacol 2009, 616:1-6. [Review].
51. Cui Y., Shen Y.T., Kalthof B., et al. Identification and functional role of β1-adrenergic receptor subtypes in primate and rodent: in vivo versus isolated myocytes. J Mol Cell Cardiol 1996, 28:1307-1317.
52. Brodde O.E., Bruck H., Leineweber K., Seyfarth T. Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol 2001, 96:528-538.
53. Kudenchuk P.J., Cobb L.A., Copass M.K., et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999, 341:871-878.
54. Kovoor P., Love A., Hall J., et al. Randomized double-blind trial of sotalol versus lignocaine in out-of-hospital refractory cardiac arrest due to ventricular tachyarrhythmia. Intern Med J 2005, 35:518-525.